CIK: 1264949 - Address: C/O Viking Therapeutics, Inc., 9920 Pacific Heights Blvd, Suite 350, San Diego, CA 92121
25 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret118-0-5-11-10-11-35-12
S%wins75888875758881

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/3/24 20:51
5/3/24
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsZante GregCAOCFOM.d1664.8603424175D
5/3/24 20:51
5/3/24
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsZante GregCAOCFOS.d-4,98674.690-67-28175D
1/4/24 21:35
1/4/24
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsZante GregCAOCFOS.d-26917.900-15-8181D
4/18/23 19:07
4/17/23
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsZante GregCAOCFOM.d9813.07085149D
4/18/23 19:07
4/17/23
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsZante GregCAOCFOS.d-15020.000-8-5149D
4/13/23 17:13
4/11/23
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsZante GregCAOCFOM.dm5455.57098190149D
4/13/23 17:13
4/11/23
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsZante GregCAOCFOS.dm-1,76118.000-98-40149D
4/3/23 19:24
3/30/23
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsZante GregCAOCFOM.dm9247.410125506149D
4/3/23 19:24
3/30/23
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsZante GregCAOCFOS.dm-2,78417.190-162-52149D
3/12/08 19:41
2/14/08
SGMOSangamo Biosciences IncDEHealthBioPrdBiological Products, (No DiagZante GregCAOVP,FinanM.d04.1160171D7244-3-32-10-15-13-140-612-14-10-65
3/12/08 19:41
2/14/08
SGMOSangamo Biosciences IncDEHealthBioPrdBiological Products, (No DiagZante GregCAOVP,FinanS.d-112.0060-131D7244-3-32-10-15-13-140-612-14-10-65
2/19/08 18:03
2/14/08
SGMOSangamo Biosciences IncDEHealthBioPrdBiological Products, (No DiagZante GregCAOVP,Fin.,M.d254.97551D1214516-21-431-14-2-1715-7-60
2/19/08 18:03
2/14/08
SGMOSangamo Biosciences IncDEHealthBioPrdBiological Products, (No DiagZante GregCAOVP,Fin.,S.d-6012.025-5-881D1214516-21-431-14-2-1715-7-60
1/10/08 18:13
1/8/08
SGMOSangamo Biosciences IncDEHealthBioPrdBiological Products, (No DiagZante GregCAOVP,Fin.,M.d244.78551D1859825-15-1-307-2-6-18-15-20-73
1/10/08 18:13
1/8/08
SGMOSangamo Biosciences IncDEHealthBioPrdBiological Products, (No DiagZante GregCAOVP,Fin.,S.d-6412.875-5-881D1859825-15-1-307-2-6-18-15-20-73
12/11/07 18:07
12/7/07
SGMOSangamo Biosciences IncDEHealthBioPrdBiological Products, (No DiagZante GregCAOVP,Fin.,M.d224.381051D2471039927-250-5-61-10-4-26-35-75
12/11/07 18:07
12/7/07
SGMOSangamo Biosciences IncDEHealthBioPrdBiological Products, (No DiagZante GregCAOVP,Fin.,S.d-7915.8010-5-881D2471039927-250-5-61-10-4-26-35-75
11/13/07 18:03
11/8/07
SGMOSangamo Biosciences IncDEHealthBioPrdBiological Products, (No DiagZante GregCAOVP,Fin.,S.d-22518.0315-13-1000D240171118453-8-20-23-3-6-7-23-10-87
11/13/07 18:03
11/8/07
SGMOSangamo Biosciences IncDEHealthBioPrdBiological Products, (No DiagZante GregCAOVP,Fin.,M.d453.7615120D240171118453-8-20-23-3-6-7-23-10-87
12/13/06 20:12
12/11/06
SGMOSangamo Biosciences IncDEHealthBioPrdBiological Products, (No DiagZante GregCAOVP,FinanM.dm1834.594400D3565-234210-9-3-1-9-7-914100
12/13/06 20:12
12/11/06
SGMOSangamo Biosciences IncDEHealthBioPrdBiological Products, (No DiagZante GregCAOVP,FinanS.dm-2807.024-40-1000D3565-234210-9-3-1-9-7-914100
6/5/06 19:21
6/1/06
SGMOSangamo Biosciences IncDEHealthBioPrdBiological Products, (No DiagZante GregCAOSr. Dir M.d243.00480D23878917314558130-5-21-293-8
6/5/06 19:21
6/1/06
SGMOSangamo Biosciences IncDEHealthBioPrdBiological Products, (No DiagZante GregCAOSr. Dir S.d-637.904-8-1000D23878917314558130-5-21-293-8
10/1/04 18:20
9/29/04
SGMOSangamo Biosciences IncDEHealthBioPrdBiological Products, (No DiagZante GregCAOSr Dir.,M.d163.00050D14722-21-172010-3-803-2222-20-10
10/1/04 18:20
9/29/04
SGMOSangamo Biosciences IncDEHealthBioPrdBiological Products, (No DiagZante GregCAOSr Dir.,S.d-275.050-5-1000D14722-21-172010-3-803-2222-20-10

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact